Sign in

CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
300409740
Phone
(415) 651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
  1. 4 Open-market sale CH. DISCOV. & NON-CLIN DEV OFF sold 26,066 shares at an average $9.01 ($234,916)
  2. 4 Open-market sale CHIEF MEDICAL OFFICER sold 27,805 shares at an average $9.01 ($250,456)
  3. 4 Open-market sale CH. OPERATING & FINANCIAL OFF. sold 35,159 shares at an average $9.01 ($316,703)
  4. 4 Open-market sale PRESIDENT AND CEO sold 109,502 shares at an average $9.01 ($986,365)
  5. 4 Returned to the company Director returned 3,369,704 shares (to the company)
  6. 4/A Open-market sale Director sold 1,175,000 shares at $14.85 ($17,448,750)
  7. 4 Option exercise Ch. Operating & Financial Off. acquired 25,000 shares (option exercise)
  8. 4 Open-market sale 10% owner sold 2,400,000 shares at $14.92 ($35,796,000)
  9. 4 Planned sale Director sold 5,000 shares at an average $15.57 ($77,872)
  10. 4 Planned sale Director sold 5,000 shares at $12.26 ($61,300)
  11. 4 Planned sale Director sold 20,000 shares at $10.77 ($215,400)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 13 · 244 filings